19.28
Stevanato Group Spa stock is traded at $19.28, with a volume of 234.69K.
It is up +1.47% in the last 24 hours and up +4.44% over the past month.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
See More
Previous Close:
$19.00
Open:
$19
24h Volume:
234.69K
Relative Volume:
0.48
Market Cap:
$5.26B
Revenue:
$1.40B
Net Income/Loss:
$164.00M
P/E Ratio:
32.09
EPS:
0.6009
Net Cash Flow:
$-11.09M
1W Performance:
+11.06%
1M Performance:
+4.44%
6M Performance:
-10.70%
1Y Performance:
-21.59%
Stevanato Group Spa Stock (STVN) Company Profile
Name
Stevanato Group Spa
Sector
Industry
Phone
-
Address
-
Compare STVN vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
STVN
Stevanato Group Spa
|
19.28 | 4.93B | 1.40B | 164.00M | -11.09M | 0.6009 |
|
ISRG
Intuitive Surgical Inc
|
432.83 | 140.84B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
155.54 | 41.70B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
MDLN
Medline Inc
|
42.75 | 33.35B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
ALC
Alcon Inc
|
68.33 | 32.72B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
RMD
Resmed Inc
|
218.40 | 28.27B | 5.54B | 1.52B | 1.74B | 10.37 |
Stevanato Group Spa Stock (STVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-03-24 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-22-24 | Initiated | Exane BNP Paribas | Outperform |
| Nov-01-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-26-23 | Initiated | Stephens | Overweight |
| Sep-19-23 | Initiated | CJS Securities | Market Outperform |
| Aug-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-10-21 | Initiated | BofA Securities | Buy |
| Aug-10-21 | Initiated | Citigroup | Buy |
| Aug-10-21 | Initiated | Jefferies | Buy |
| Aug-10-21 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-10-21 | Initiated | Morgan Stanley | Overweight |
| Aug-10-21 | Initiated | Wells Fargo | Overweight |
View All
Stevanato Group Spa Stock (STVN) Latest News
STVNStevanato Group Spa Latest SEC Filings - Finviz
Stevanato Group (NYSE:STVN) Shares Gap UpWhat's Next? - MarketBeat
TimesSquare Mid Cap Growth Strategy Downplays Market Fears on Stevanato Group S.p.A. (STVN) - Insider Monkey
(STVN) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Enterprise value to revenue forward of Stevanato Group S.p.A. – NYSE:STVN - TradingView
Price to sales forward of Stevanato Group S.p.A. – NYSE:STVN - TradingView
Stevanato Group SpA Actuals & Estimates (NYSE:STVN) - TradingView
Price to sales forward of Stevanato Group SpA – LSX:A3CUMB - TradingView
Price to book forward of Stevanato Group SpA – LSX:A3CUMB - TradingView
STVN SEC FilingsStevanato Group S P A 10-K, 10-Q, 8-K Forms - Stock Titan
Stevanato Group (STVN) director granted 4,975 shares, sells 1,493 to cover taxes - Stock Titan
[Form 4] Stevanato Group S.p.A. Insider Trading Activity - Stock Titan
Director Sue-Jean Lin granted 4,975 Stevanato Group (STVN) shares as equity pay - Stock Titan
Stevanato (NYSE: STVN) director gets share grant, sells some for taxes - Stock Titan
Luciano Santel receives 4,975 Stevanato (STVN) shares as director pay - Stock Titan
Director Magistretti receives 4,975 Stevanato Group (STVN) shares as equity grant - Stock Titan
Stevanato Group (STVN) officer gains shares through PSUs and RSU awards - Stock Titan
Stevanato Group (STVN) director granted shares, sells portion to cover taxes - Stock Titan
Stevanato Group (STVN) director granted 4,975 shares, sells 1,493 to pay taxes - Stock Titan
Stevanato Group SpA Actuals & Estimates (DUS:87N) - TradingView
STVN Forecast — Price Target — Prediction for 2027 - TradingView
Stevanato Group SpA (STVN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Stevanato Group SpA (STVN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a 39% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Stevanato Group SpA (STVN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Stevanato Group SpA (STVN) Institutional Confidence - TradingKey
Stevanato Group SpA (STVN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
(STVN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Stevanato Group SpA (STVN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Stevanato Group SpA (STVN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Stevanato Group SpA (STVN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Stevanato Group SpA (STVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TD Cowen initiates Stevanato stock with buy rating on margin outlook By Investing.com - Investing.com South Africa
TD Cowen initiates Stevanato stock with buy rating on margin outlook - Investing.com
Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a 42.79% Potential Upside in the Medical Instruments Sector - DirectorsTalk Interviews
Stevanato Group (STVN) Stock Valuation Check After Recent Share Price Weakness - Yahoo Finance
Sustainable Pharmaceutical Packaging Market to Reach USD 270.4 Billion by 2031, Wissen Research - Moomoo
Is Stevanato Group S.p.A. (STVN) A Good Stock To Buy Now? - Insider Monkey
Stevanato: HVS Momentum Overshadows Engineering Weakness, Offering Compelling Upside - Seeking Alpha
Stevanato Group launches pen injector for diabetes drugs By Investing.com - Investing.com Nigeria
2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now - The Motley Fool
Stevanato Group launches Deora pen injector platform targeting GLP-1 and incretin therapies - Manufacturing Chemist
Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneo - GuruFocus
Stevanato Group (STVN) Q1 2026 Earnings: EPS Beats Estimates Amid Quiet Revenue DisclosureShort-Term Outlook - newsline.com
Stevanato Group Launches Deora Pen Injector for Diabetes and Weight Management Therapies - World Business Outlook
Stevanato Group launches pen injector platform targeting GLP-1, obesity drug market - Medical Economics
Stevanato Group Introduces New Proprietary Pen Injector Platform - Contract Pharma
Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management - Stevanato Group S.p.A. (STVN)
Stevanato Group launches pen injector for diabetes drugs - Investing.com UK
Stevanato Group S.p.A. (STVN): Analyst Consensus Highlights 32.12% Potential Upside - DirectorsTalk Interviews
Stevanato Group S.p.A (STVN) Q4 2023 Earnings Call Transcript - MLQ.ai
Stevanato Group Spa Stock (STVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Stevanato Group Spa Stock (STVN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dal Lago Marco | Chief Financial Officer |
Jun 12 '26 |
Option Exercise |
0.00 |
7,997 |
0 |
85,353 |
| MOREL DONALD E JR | Director |
Jun 15 '26 |
Sale |
17.09 |
1,493 |
25,515 |
37,424 |
| Stocchi Mauro | See Remarks |
Jun 09 '26 |
Option Exercise |
0.00 |
6,586 |
0 |
413,629 |
| Flynn Karen | Director |
Jun 15 '26 |
Sale |
17.09 |
1,493 |
25,515 |
5,757 |
| FEDERICI WILLIAM J | Director |
Jun 15 '26 |
Sale |
17.09 |
1,493 |
25,515 |
26,991 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):